Palantir: AI Bargain With A Moat
Palantir delivered a standout Q1 with 85% YoY revenue growth to $1.63B and 60% adjusted operating ma…

Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.
1 signal unavailable — limited data for this stock
Trend
+7.5% vs SMA 50 · -2.0% vs SMA 200
Momentum
Analyst consensus estimates · Actuals replace estimates as reported
| Year | Revenue Est. | Rev Gth | EPS Est. | EPS Gth | Range | Analysts |
|---|---|---|---|---|---|---|
FY2025 | $3.0M $2.4M–$3.6M | — | -$0.62 | — | ±5% | High9 |
FY2026(current) | $507692 $507692–$507692 | ▼ -83.1% | -$0.48 | — | ±41% | High9 |
FY2027 | $240000 $240000–$240000 | ▼ -52.7% | -$0.49 | — | ±34% | High8 |
Palantir delivered a standout Q1 with 85% YoY revenue growth to $1.63B and 60% adjusted operating ma…

who we are: atai is a global biotech company builder that leverages a decentralized, technology- and data-driven platform model to serve millions of people suffering from mental health disorders. our mission: we are committed to acquiring and efficiently developing innovative treatments that address significant unmet medical needs and lead to paradigm shifts in the mental health space. our approach: by pooling expertise, best practices, and resources across our entire portfolio, we mitigate risk and responsibly accelerate the development of impactful and evidence-based treatments.